This New Product Is Central to mRNA Vaccines -- But Should You Buy the Stock?The Motley Fool • 06/09/21
Immutep, Merck Germany Team Up for Eftilagimod/Bintrafusp Combo Trial In Solid TumorsBenzinga • 06/01/21
Data from Merck's Oncology Portfolio Highlight Significant Advances in Cancer Care at ASCO21Business Wire • 05/19/21
Merck Announces New Data Strengthening Evidence for Continued Safe and Effective MAVENCLAD® Use During the COVID-19 PandemicBusiness Wire • 04/23/21
Merck Advances ATR Inhibitor Berzosertib in Small Cell Lung Cancer With New Published Data and Initiation of Phase II Trial With Registrational IntentBusiness Wire • 04/12/21